Mehul Joshi serves as the Chief Financial Officer at Pulmonx Corp, a leading medical technology company focused on innovative treatments for lung diseases. With a robust background in finance and healthcare, Joshi has been instrumental in steering Pulmonx towards financial stability and growth. Prior to joining Pulmonx, Joshi held various senior financial roles at prominent healthcare companies, including CFO positions at LivaNova PLC and Thoratec Corporation. His extensive experience in financial strategy and operations has been a key asset to Pulmonx as they continue to expand their market presence and product offerings. In his role as CFO at Pulmonx, Joshi is responsible for overseeing the company's financial operations, including accounting, financial planning, and investor relations. His strategic vision has been crucial in navigating the complex financial landscape of the medical technology sector. Under his leadership, Pulmonx has successfully managed to secure funding and investments to support its research and development initiatives. Joshi's ability to communicate effectively with stakeholders and his deep understanding of the industry have helped Pulmonx maintain a strong financial position, even amidst the challenges posed by the global healthcare market. Joshi's achievements extend beyond his current role at Pulmonx. He has been recognized for his contributions to the finance and healthcare sectors, earning accolades for his leadership and strategic foresight. His tenure at LivaNova and Thoratec saw significant improvements in financial performance and operational efficiency, setting a strong foundation for his work at Pulmonx. Joshi's commitment to driving innovation and growth while maintaining fiscal responsibility makes him a vital part of Pulmonx's leadership team, as they work towards improving patient outcomes and advancing the field of lung disease treatment.